A Message from the ESMO President By Ogkologos - March 17, 2020 636 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Could A Form of Cell Death Enhance Cancer Immunotherapy? July 29, 2019 Ibrutinib-Containing Immunochemotherapy in Front-Line Treatment of Young, Medically Fit Patients with... May 14, 2024 How Early Cancer Detection and Diagnosis Saved My Life Twice: A... December 27, 2023 Cancer in My Community: Overcoming Delays in Care for Children With... July 6, 2023 Load more HOT NEWS EMA Recommends Extension of Indications for Ibrutinib Preoperative ctDNA Levels Are Detectable in the Majority of Patients with... The new home for your research tools Bringing the Cancer Community Back Together at ASCO Annual Meeting: Why...
